Gabor Mezo
Gabor Mezo
ELTE-MTA Peptidkémiai Kutatócsoport
Verified email at elte.hu
TitleCited byYear
Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies
GG Kovács, L László, J Kovács, PH Jensen, E Lindersson, G Botond, ...
Neurobiology of disease 17 (2), 155-162, 2004
1252004
Dual Labeling of Biomolecules by Using Click Chemistry: A Sequential Approach PK thanks the Humboldt Foundation for a Humboldt fellowship (3.3-UNG/1126507). Financial support …
P Kele, G Mezo, D Achatz, OS Wolfbeis
Angewandte Chemie-International Edition 48 (2), 344, 2010
119*2010
Dual labeling of biomolecules by using click chemistry: a sequential approach
P Kele, G Mezö, D Achatz, OS Wolfbeis
Angewandte Chemie International Edition 48 (2), 344-347, 2009
1192009
Application of Marfey's reagent in racemization studies of amino acids and peptides
G Szókán, G Mezö, F Hudecz
Journal of Chromatography A 444, 115-122, 1988
1011988
Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmenbrane glycoprotein gq41 of HIV-1
P Csermely, 愒er, F Hudecz
Molecular immunology 34 (11), 809-816, 1997
961997
Receptor-mediated tumor targeting based on peptide hormones
G Mezo, M Manea
Expert Opinion on Drug Delivery 7 (1), 79-96, 2010
922010
In vitro degradation and antitumor activity of oxime bond-linked daunorubicin–GnRH-III bioconjugates and DNA-binding properties of daunorubicin–amino acid metabolites
E Orbán, G Mező, P Schlage, G Csík, Ž Kulić, P Ansorge, E Fellinger, ...
Amino acids 41 (2), 469-483, 2011
662011
The effect of cyclization on the enzymatic degradation of herpes simplex virus glycoprotein D derived epitope peptide
R Tugyi, G Mezö, E Fellinger, D Andreu, F Hudecz
Journal of Peptide Science 11 (10), 642-649, 2005
642005
Characterization of intertype specific epitopes on adenovirus hexons
E Adam, I Nasz, F Hudecz, A Lengyel, G Mezö, O Dobay
Archives of virology 143 (9), 1669-1682, 1998
571998
New derivatives of GnRH as potential anticancer therapeutic agents
G Mezo, M Manea, I Szabó, B Vincze, M Kovács
Current medicinal chemistry 15 (23), 2366-2379, 2008
552008
Carrier design: biodistribution of branched polypeptides with a poly (L-lysine) backbone
JA Clegg, F Hudecz, G Mezo, MV Pimm, M Szekerke, RW Baldwin
Bioconjugate chemistry 1 (6), 425-430, 1990
551990
Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug
I Szabó, M Manea, E Orbán, A Csámpai, S Bősze, R Szabó, M Tejeda, ...
Bioconjugate chemistry 20 (4), 656-665, 2009
542009
Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockers
YX Wang, S Bezprozvannaya, SS Bowersox, L Nadasdi, G Miljanich, ...
Naunyn-Schmiedeberg's archives of pharmacology 357 (2), 159-168, 1998
541998
Interaction of β-amyloid (1-40) peptide with pairs of metal ions: An electrospray ion trap mass spectrometric model study
G Drochioiu, M Manea, M Dragusanu, M Murariu, ES Dragan, BA Petre, ...
Biophysical chemistry 144 (1), 9-20, 2009
442009
Carrier design: Synthesis and conformational studies of poly (L‐lysine) based branched polypeptides with hydroxyl groups in the side chains
G Mezö, J Kajtár, I Nagy, M Szekerke, F Hudecz
Biopolymers 42 (6), 719-730, 1997
421997
Syntheses and DNA binding of new cationic porphyrin-tetrapeptide conjugates
G Mezo, L Herényi, J Habdas, Z Majer, B Mysliwa-Kurdziel, K TŰth, ...
Biophysical Chemistry, 2011
412011
Carrier design: cytotoxicity and immunogenicity of synthetic branched polypeptides with poly (L-lysine) backbone
F Hudecz, D Gaál, I Kurucz, Á Lányi, AL Kovács, G Mezö, É Rajnavölgyi, ...
Journal of controlled release 19 (1), 231-243, 1992
401992
Synthesis and Comparison of Antibody Recognition of Conjugates Containing Herpes Simplex Virus Type 1 Glycoprotein D Epitope VII1
G Mezö, E de Oliveira, D Krikorian, M Feijlbrief, A Jakab, V Tsikaris, ...
Bioconjugate chemistry 14 (6), 1260-1269, 2003
392003
Carrier design: new generation of polycationic branched polypeptides containing OH groups with prolonged blood survival and diminished in vitro cytotoxicity
F Hudecz, MV Pimm, É Rajnavölgyi, G Mezo, A Fabra, D Gaál, AL Kovács, ...
Bioconjugate chemistry 10 (5), 781-790, 1999
391999
Anthracycline-GnRH derivative bioconjugates with different linkages: Synthesis, in vitro drug release and cytostatic effect
P Schlage, G Mezo, E Orbán, S Bosze, M Manea
Journal of Controlled Release, 2011
382011
The system can't perform the operation now. Try again later.
Articles 1–20